Blood tests that measure the amount of cholesterol and triglycerides in your blood are a routine part of most annual checkups. When levels of these substances are not optimal, they can raise your risk ...
Cholesterol and triglycerides are types of lipids. They travel in our blood by attaching to proteins. Adults 20 and older should ask their health care team about their lipid profile and how to ...
In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients with severe hypertriglyceridemia by more than 60%, according to a preliminary ...
Older people who have fluctuating levels of cholesterol and triglycerides may have a higher risk of Alzheimer's disease and related dementias compared to people who have steady levels, according to ...
EDITOR’S NOTE: Sign up for CNN’s Eat, But Better: Mediterranean Style. Our eight-part guide shows you a delicious expert-backed eating lifestyle that will boost your health for life. The fact that ...
NDTV Profit on MSN
IIT Bombay-led team develops peptide that cuts cholesterol, triglyceride release by nearly 50%
Researchers at IIT-B reported no harmful fat buildup in the liver, with excess fatty acids instead being broken down to ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
A regular cholesterol test is useful, but it doesn't always capture the complete picture of heart disease risk.
Dr Vinayak Agrawal explains why looking at multiple lipids is necessary to determine the heart health of lean Indians. Here ...
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
Older people who have fluctuating levels of cholesterol and triglycerides may have a higher risk of Alzheimer's disease and related dementias compared to people who have steady levels, according to ...
In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results